套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011664 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011666 Size: 9 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011669 Size: 8 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011670 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011671 Size: 8 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011674 Size: 42 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011677 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011678 Size: 13 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011680 Size: 47 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011681 Size: 18 KB 网页链接